NCT00616694View on ClinicalTrials.gov

Impact of Vertebral Fracture Knowledge on Persistence in Subjects Taking Glucocorticoid Therapy

PHASE4CompletedINTERVENTIONAL
Enrollment

248

Participants

Timeline

Start Date

July 31, 2002

Study Completion Date

December 31, 2004

Conditions
Osteoporosis
Interventions
DRUG

Actonel

Actonel 5 mg orally once daily (OD), calcium 500 mg + vitamin D 200 units twice daily (BID)

Trial Locations (1)

08807

Sanofi-Aventis, Bridgewater

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY

NCT00616694 - Impact of Vertebral Fracture Knowledge on Persistence in Subjects Taking Glucocorticoid Therapy | Biotech Hunter | Biotech Hunter